Search results for Bevacizumab - Clinical Trials Registry

Example: Heart Attack

Search clinical trials for: Bevacizumab

Total 2058 results

NCT05063552

Recruiting

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

Conditions: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma, Metastatic Lip and Oral Cavity Carcinoma, Metastatic Nasal Cavity Squamous Cell Carcinoma, Metastatic Nasopharyngeal Squamous Cell Carcinoma, Metastatic Pharyngeal Squamous Cell Carcinoma, Metastatic Sinonasal Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Lip and Oral Cavity Squamous Cell Carcinoma, Recurrent Nasopharyngeal Squamous Cell Carcinoma, Recurrent Pharyngeal Squamous Cell Carcinoma, Recurrent Sinonasal Squamous Cell Carcinoma, Stage IV Hypopharyngeal Carcinoma AJCC v8, Stage IV Laryngeal Cancer AJCC v8, Stage IV Lip and Oral Cavity Cancer AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Sinonasal Cancer AJCC v8
NCT04310176

Recruiting

Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer

Conditions: Ras-mutated Metastatic Colorectal Cancer
NCT05785325

Not yet recruiting

RC48-ADC Combined With Bevacizumab in HER2-positive Advanced Colorectal Cancer

Conditions: Colorectal Cancer
NCT02873962

Active, not recruiting

A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

Conditions: Peritoneal Cancer, Ovarian Cancer, Fallopian Tube Cancer
NCT01445509

Completed

Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors

Conditions: Solid Tumors
NCT04185883

Recruiting

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Conditions: Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation
NCT04094688

Recruiting

Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

Conditions: Colorectal Adenocarcinoma
NCT02633189

Active, not recruiting

Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer

Conditions: Non-squamous Non-small Cell Lung Cancer
NCT01802749

Active, not recruiting

Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer

Conditions: Recurrent Ovarian Cancer
NCT01706120

Active, not recruiting

Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab

Conditions: Ovarian Cancer
NCT05781633

Recruiting

The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.

Conditions: Mammary Neoplasms, Human
NCT05262244

Recruiting

Targeted Fluorescence Imaging in AMD

Conditions: Age-Related Macular Degeneration
NCT05253651

Recruiting

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Conditions: Colorectal Neoplasms
NCT05001880

Recruiting

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

Conditions: Peritoneal Malignant Mesothelioma
NCT04181060

Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Conditions: Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8
NCT05781308

Not yet recruiting

Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy

Conditions: Non Small Cell Lung Cancer
NCT03498521

Active, not recruiting

A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site

Conditions: Cancer of Unknown Primary Site
NCT04862949

Completed

Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC

Conditions: Advanced Hepatocellular Carcinoma
NCT02490878

Terminated

Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases

Conditions: Radionecrosis, Brain Metastases
NCT03280563

Active, not recruiting

A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

Conditions: Breast Neoplasms
NCT05616390

Recruiting

Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma

Conditions: Hepatocellular Carcinoma
NCT05087992

Recruiting

A Study to Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal Cancers

Conditions: Gastrointestinal Cancer, Metastatic
NCT05337137

Recruiting

A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer

Conditions: Carcinoma, Hepatocellular
NCT05180006

Recruiting

Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy

Conditions: Breast Cancer
NCT05775159

Not yet recruiting

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

Conditions: Hepatocellular Carcinoma, Biliary Tract Cancer

Search clinical trials for: Bevacizumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations